Cargando…

Use of non-TNF biologics for the treatment of neuro-Behçet's disease: Literature review and 2 refractory cases of monoclonal anti-TNFs treated with tocilizumab

Neurological complications of BD (neuro-Behçet's disease [NBD]) are life-threatening and disabling manifestations. Neurological involvement occurs in approximately 5% to 18% of patients with BD. Most patients with NBD respond well to glucocorticoids, cyclophosphamide, or anti-tumor necrosis fac...

Descripción completa

Detalles Bibliográficos
Autor principal:	Karabulut, Yusuf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Research and Education Association 2022
Materias:	Literature Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176236/ https://www.ncbi.nlm.nih.gov/pubmed/34554909 http://dx.doi.org/10.5152/eurjrheum.2021.20160

Ejemplares similares

Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: case series and literature review
por: Liu, Jinjing, et al.
Publicado: (2020)

Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
por: Desbois, Anne Claire, et al.
Publicado: (2016)

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
por: Thomsen, Simon Francis, et al.
Publicado: (2015)

Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management
por: Roda, Giulia, et al.
Publicado: (2016)

Biologic treatments in Behçet's disease
por: Alibaz-Öner, Fatma, et al.
Publicado: (2022)

Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
por: Roda, Giulia, et al.
Publicado: (2019)

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
por: Hwang, Sungeun, et al.
Publicado: (2021)

Tocilizumab for refractory Castleman’s disease with paraneoplastic pemphigus and Behçet’s disease
por: Vargas, Ana Beatriz, et al.
Publicado: (2012)

Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease
por: Salvador-Martín, Sara, et al.
Publicado: (2021)

Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active disease
por: Taylor, Peter C., et al.
Publicado: (2023)

TNF and anti-TNF agents in Behçet's disease
por: Calamia, KT
Publicado: (2003)

Biological Treatments in Behçet's Disease: Beyond Anti-TNF Therapy
por: Caso, Francesco, et al.
Publicado: (2014)

When rheumatology meets hepatology: are anti-TNFs safe in hepatitis B virus carriers?
por: Jansen, Tim L
Publicado: (2010)

Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease
por: Prieto-Pérez, Rocío, et al.
Publicado: (2016)

Neuro-Behcet disease
por: Zhang, Lin, et al.
Publicado: (2021)

Neuro-Behcet's syndrome: Case report and literature review()
por: Peine, Brian, et al.
Publicado: (2022)

Anti-TNF-α agents for refractory intestinal Behçet’s disease: case series and meta-analysis
por: Zhan, Shukai, et al.
Publicado: (2022)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

PReS-FINAL-2250: Presentation of tuberculosis in patients using anti-TNFS drugs: report of 3 cases
por: Bica, BE, et al.
Publicado: (2013)

High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021)

Neuro-Behçets in a Child
por: Vesoulis, Zachary A., et al.
Publicado: (2014)

Chorea in Neuro-Behçet’s Disease
por: Hamid, Mohamed, et al.
Publicado: (2021)

Neuro-Behçet’s Disease With Coma
por: Hamid, Mohamed, et al.
Publicado: (2022)

Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
por: Hirabara, Shinya, et al.
Publicado: (2014)

Neuro-Behçet Disease, Neuro-Sweet Disease, and Spectrum Disorders
por: Hisanaga, Kinya
Publicado: (2021)

Neuro-Behcet's: a diagnostic challenge
por: Mohan, Mithun Cherakara, et al.
Publicado: (2015)

Kleptomania in Patients with Neuro-Behçet's Disease
por: Shugaiv, Erkingül, et al.
Publicado: (2013)

A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)
por: Ramanan, Athimalaipet V., et al.
Publicado: (2018)

The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
por: Hisamatsu, Tadakazu, et al.
Publicado: (2013)

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
por: Zhuleku, Evi, et al.
Publicado: (2022)

Neuro-Behçet’s disease in childhood: A focus on the neuro-ophthalmological features
por: Mora, Paolo, et al.
Publicado: (2013)

MEFV gene mutations in neuro‐Behçet's disease and neuro‐Sweet disease
por: Ishikawa, Hidehiro, et al.
Publicado: (2019)

Efficacy and safety of tocilizumab in Behçet’s syndrome with refractory arterial lesions: a single-centre observational cohort study in China
por: Zhong, Hua, et al.
Publicado: (2021)

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
por: Fossati, G, et al.
Publicado: (2010)

Neuro-Behçet's Disease Presenting as Hypertrophic Pachymeningitis
por: Yoon, Byung-Nam, et al.
Publicado: (2015)

Delirium as presenting symptom of neuro-Behcet’s disease
por: Alnasser Alsukhni, Rana, et al.
Publicado: (2016)

Clinical characteristics and prognosis of Neuro-Behçet’s disease
por: Sorgun, Mine Hayriye, et al.
Publicado: (2018)

Nutritional status in patients with neuro-Behçet’s disease
por: ERDOĞAN, Seyda, et al.
Publicado: (2021)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Difference between the MRI Findings for Neuro-Behçet Disease and Neuro-Sweet Disease
por: Shimazaki, Rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aeegeocc9a9c7bjgk246bhqdj8